MENY

Vägledning för bäckenrehabilitering

Fastställt av Regionala cancercentrum i samverkan 2018-08-21.

10. Referenser

1.Andreyev J. Gastrointestinal symptoms after pelvic radiotherapy: a new understanding to improve management of symptomatic patients. Lancet Oncol. 2007;8(11):1007-17.

2.Westbury CB, Yarnold JR. Radiation fibrosis--current clinical and therapeutic perspectives. Clin Oncol (R Coll Radiol). 2012;24(10):657-72.

3.Muls AC, Watson L, Shaw C, Andreyev HJN. Managing gastrointestinal symptoms after cancer treatment: a practical approach for gastroenterologists. Frontline Gastroenterol. 2013;4(1):57-68.

4.Alexandrescu DT, Dutcher JP, Wiernik PH. Capecitabine-induced pancolitis. Int J Colorectal Dis. 2007;22(4):455.

5.Gibson RJ, Keefe DM. Cancer chemotherapy-induced diarrhoea and constipation: mechanisms of damage and prevention strategies. Support Care Cancer. 2006;14(9):890-900.

6.Ottillinger B, Storr M, Malfertheiner P, Allescher HD. STW 5 (Iberogast(R))--a safe and effective standard in the treatment of functional gastrointestinal disorders. Wien Med Wochenschr. 2013;163(3-4):65-72.

7.Dukowicz AC, Lacy BE, Levine GM. Small intestinal bacterial overgrowth: a comprehensive review. Gastroenterol Hepatol (N Y). 2007;3(2):112-22.

8.Smith GM, Chesner IM, Asquith P, Leyland MJ. Small intestinal bacterial overgrowth in patients with chronic lymphocytic leukaemia. J Clin Pathol. 1990;43(1):57-9.

9.Sieczkowska A, Landowski P, Gibas A, Kaminska B, Lifschitz C. Long-term proton pump inhibitor therapy leads to small bowel bacterial overgrowth as determined by breath hydrogen and methane excretion. J Breath Res. 2018;12(3):036006.

10.Petrone P, Sarkisyan G, Fernandez M, Coloma E, Akopian G, Ortega A, et al. Small intestinal bacterial overgrowth in patients with lower gastrointestinal symptoms and a history of previous abdominal surgery. Arch Surg. 2011;146(4):444-7.

11.Gasbarrini A, Lauritano EC, Gabrielli M, Scarpellini E, Lupascu A, Ojetti V, et al. Small intestinal bacterial overgrowth: diagnosis and treatment. Dig Dis. 2007;25(3):237-40.

12.Pattni S, Walters JR. Recent advances in the understanding of bile acid malabsorption. Br Med Bull. 2009;92:79-93.

13.Andreyev HJ. Gastrointestinal problems after pelvic radiotherapy: the past, the present and the future. Clin Oncol (R Coll Radiol). 2007;19(10):790-9.

14.Maringhini A, Gertz MA, DiMagno EP. Exocrine pancreatic insufficiency after allogeneic bone marrow transplantation. International journal of pancreatology : official journal of the International Association of Pancreatology. 1995;17(3):243-7.

15.Parnes HL, Fung E, Schiffer CA. Chemotherapy-induced lactose intolerance in adults. Cancer. 1994;74(5):1629-33.

16.Weiner JP, Wong AT, Schwartz D, Martinez M, Aytaman A, Schreiber D. Endoscopic and non-endoscopic approaches for the management of radiation-induced rectal bleeding. World J Gastroenterol. 2016;22(31):6972-86.

17.Wu XR, Liu XL, Katz S, Shen B. Pathogenesis, diagnosis, and management of ulcerative proctitis, chronic radiation proctopathy, and diversion proctitis. Inflammatory bowel diseases. 2015;21(3):703-15.

18.Gami B, Harrington K, Blake P, Dearnaley D, Tait D, Davies J, et al. How patients manage gastrointestinal symptoms after pelvic radiotherapy. Aliment Pharmacol Ther. 2003;18(10):987-94.

19.McElvanna K, Wilson A, Irwin T. Sucralfate paste enema: a new method of topical treatment for haemorrhagic radiation proctitis. Colorectal Dis. 2014;16(4):281-4.

20.Phan J, Swanson DA, Levy LB, Kudchadker RJ, Bruno TL, Frank SJ. Late rectal complications after prostate brachytherapy for localized prostate cancer: incidence and management. Cancer. 2009;115(9):1827-39.

21.Koessler T, Servois V, Mariani P, Aubert E, Cacheux W. Rectal ulcer: Due to ketoprofen, argon plasma coagulation and prostatic brachytherapy. World J Gastroenterol. 2014;20(45):17244-6.

22.Goldinger M. [Radiation-induced hemorrhagic proctitis treated with formalin. A simple and efficient help against adverse effects of radiation]. Lakartidningen. 1998;95(11):1142-3.

23.Tahir AR, Westhuyzen J, Dass J, Collins MK, Webb R, Hewitt S, et al. Hyperbaric oxygen therapy for chronic radiation-induced tissue injuries: Australasia's largest study. Asia-Pacific journal of clinical oncology. 2015;11(1):68-77.

24.Oscarsson N, Arnell P, Lodding P, Ricksten SE, Seeman-Lodding H. Hyperbaric oxygen treatment in radiation-induced cystitis and proctitis: a prospective cohort study on patient-perceived quality of recovery. Int J Radiat Oncol Biol Phys. 2013;87(4):670-5.

25.Barton MB, Peters LJ, Kenny LM. Radiotherapy in Australia one year after the Baume report: vision or mirage? Med J Aust. 2004;180(2):55-6.

26.Juul T, Ahlberg M, Biondo S, Emmertsen KJ, Espin E, Jimenez LM, et al. International validation of the low anterior resection syndrome score. Ann Surg. 2014;259(4):728-34.

27.Itagaki R, Koda K, Yamazaki M, Shuto K, Kosugi C, Hirano A, et al. Serotonin (5-HT3) receptor antagonists for the reduction of symptoms of low anterior resection syndrome. Clin Exp Gastroenterol. 2014;7:47-52.

28.Visser WS, Te Riele WW, Boerma D, van Ramshorst B, van Westreenen HL. Pelvic floor rehabilitation to improve functional outcome after a low anterior resection: a systematic review. Ann Coloproctol. 2014;30(3):109-14.

29.Rosen H, Robert-Yap J, Tentschert G, Lechner M, Roche B. Transanal irrigation improves quality of life in patients with low anterior resection syndrome. Colorectal Dis. 2011;13(10):e335-8.

30.Ramage L, Qiu S, Kontovounisios C, Tekkis P, Rasheed S, Tan E. A systematic review of sacral nerve stimulation for low anterior resection syndrome. Colorectal Dis. 2015;17(9):762-71.

31.Nathorst-Böös J vSB, Carlström K. Elective ovarian removal and estrogen replacement therapy: effects on sexual life, psychological well-being and androgen status. J Psychosom Obstet Gynaecol. 1993:14:283-93.

32.A A. Prophylactic oophorectomy at elective hysterectomy [dissertation]. 2004.

33.Danielsson I, Sjoberg I, Stenlund H, Wikman M. Prevalence and incidence of prolonged and severe dyspareunia in women: results from a population study. Scand J Public Health. 2003;31(2):113-8.

34.Bergmark K ÅLE, Steineck G. Gynekologisk cancer påverkar ofta sexualliteten. Läkartidningen. 2000;2000;97, nr 46: 5347-5355.

35.Horden AJ SA. Communicating about patient sexuality and intimacy after cancer: mismatched expectations and unmet needs. Med J Aust. 2007;2007:186:224-7.

36.Floter A, Nathorst-Boos J, Carlstrom K, von Schoultz B. Addition of testosterone to estrogen replacement therapy in oophorectomized women: effects on sexuality and well-being. Climacteric. 2002;5(4):357-65.

37.Goldstat R, Briganti E, Tran J, Wolfe R, Davis SR. Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women. Menopause. 2003;10(5):390-8.

38.Chung E, Brock G. Sexual rehabilitation and cancer survivorship: a state of art review of current literature and management strategies in male sexual dysfunction among prostate cancer survivors. J Sex Med. 2013;10 Suppl 1:102-11.

39.Incrocci L, Jensen PT. Pelvic radiotherapy and sexual function in men and women. J Sex Med. 2013;10 Suppl 1:53-64.

40.Watkins Bruner D, James JL, Bryan CJ, Pisansky TM, Rotman M, Corbett T, et al. Randomized, double-blinded, placebo-controlled crossover trial of treating erectile dysfunction with sildenafil after radiotherapy and short-term androgen deprivation therapy: results of RTOG 0215. J Sex Med. 2011;8(4):1228-38.

41.White ID, Wilson J, Aslet P, Baxter AB, Birtle A, Challacombe B, et al. Development of UK guidance on the management of erectile dysfunction resulting from radical radiotherapy and androgen deprivation therapy for prostate cancer. Int J Clin Pract. 2015;69(1):106-23.

42.Crew JP, Jephcott CR, Reynard JM. Radiation-induced haemorrhagic cystitis. Eur Urol. 2001;40(2):111-23.

43.Stillwell TJ, Benson RC, Jr. Cyclophosphamide-induced hemorrhagic cystitis. A review of 100 patients. Cancer. 1988;61(3):451-7.

44.Stillwell TJ, Benson RC, Jr., Burgert EO, Jr. Cyclophosphamide-induced hemorrhagic cystitis in Ewing's sarcoma. J Clin Oncol. 1988;6(1):76-82.

45.Stillwell TJ, Benson RC, Jr., DeRemee RA, McDonald TJ, Weiland LH. Cyclophosphamide-induced bladder toxicity in Wegener's granulomatosis. Arthritis Rheum. 1988;31(4):465-70.

46.Bulletins--Gynecology ACoP. ACOG Practice Bulletin No. 51. Chronic pelvic pain. Obstet Gynecol. 2004;103(3):589-605.

47.Andrews J, Yunker A, Reynolds WS, Likis FE, Sathe NA, Jerome RN.  Noncyclic Chronic Pelvic Pain Therapies for Women: Comparative Effectiveness. AHRQ Comparative Effectiveness Reviews. Rockville (MD)2012.

48.Ikushima H, Osaki K, Furutani S, Yamashita K, Kishida Y, Kudoh T, et al. Pelvic bone complications following radiation therapy of gynecologic malignancies: clinical evaluation of radiation-induced pelvic insufficiency fractures. Gynecol Oncol. 2006;103(3):1100-4.

49.Oh D, Huh SJ, Nam H, Park W, Han Y, Lim DH, et al. Pelvic insufficiency fracture after pelvic radiotherapy for cervical cancer: analysis of risk factors. Int J Radiat Oncol Biol Phys. 2008;70(4):1183-8.

50.Vårdprogram för cancerrehabilitering 2014 2014. Available from: https://cancercentrum.se/globalassets/vara-uppdrag/rehabilitering-palliativ-vard/vardprogram/natvp_cancerrehabilitering_maj2014_kunskapsunderlag.pdf.

51.Quasthoff S, Hartung HP. Chemotherapy-induced peripheral neuropathy. J Neurol. 2002;249(1):9-17.

52.Wolf S, Barton D, Kottschade L, Grothey A, Loprinzi C. Chemotherapy-induced peripheral neuropathy: prevention and treatment strategies. Eur J Cancer. 2008;44(11):1507-15.

53.Nationellt Vårdprogram för Cancerrehabilitering 2017: Regionala cancercentrum i samverkan; 2017. Available from: https://www.cancercentrum.se/samverkan/vara-uppdrag/cancerrehabilitering/vardprogram/.

54.Vårdhandboken - Översikt - Lymfödem, vård och behandling. Available from: http://www.vardhandboken.se/Texter/Lymfodem-vard-och-behandling/Oversikt/.

55.Vårdprogram lymfödem: Svensk förening för lymfologi (SFL). Available from: http://www.lymfologi.se/vardprogram-lymfodem/.

56.Hayes SC, Janda M, Ward LC, Reul-Hirche H, Steele ML, Carter J, et al. Lymphedema following gynecological cancer: Results from a prospective, longitudinal cohort study on prevalence, incidence and risk factors. Gynecol Oncol. 2017;146(3):623-9.

57.Zaleska M, Olszewski WL, Jain P, Gogia S, Rekha A, Mishra S, et al. Pressures and timing of intermittent pneumatic compression devices for efficient tissue fluid and lymph flow in limbs with lymphedema. Lymphatic research and biology. 2013;11(4):227-32.

58.Lymfödem: Internetmedicin Available from: https://www.internetmedicin.se/page.aspx?id=6555.

59.Lee D PN, Hoffner M, Manjer J, Brorson H. Liposuction of postmastectomy arm lymphedema decreases the incidence of erysipelas. Lymphology 49. 2016;49:85-92.

60.Mottacki N, Simren M, Bajor A. Review article: bile acid diarrhoea - pathogenesis, diagnosis and management. Aliment Pharmacol Ther. 2016;43(8):884-98.

61.Muls AC. Acta Oncologica Lecture. Gastrointestinal consequences of cancer treatment and the wider context: a bad gut feeling. Acta oncologica (Stockholm, Sweden). 2014;53(3):297-306.

62.Holick MF. Vitamin D deficiency. The New England journal of medicine. 2007;357(3):266-81.

63.Glerup H, Mikkelsen K, Poulsen L, Hass E, Overbeck S, Thomsen J, et al. Commonly recommended daily intake of vitamin D is not sufficient if sunlight exposure is limited. Journal of internal medicine. 2000;247(2):260-8.

64.Godar DE, Pope SJ, Grant WB, Holick MF. Solar UV doses of young Americans and vitamin D3 production. Environmental health perspectives. 2012;120(1):139-43.

65.D-vitamin: Livsmedelsverket. Available from: https://www.livsmedelsverket.se/livsmedel-och-innehall/naringsamne/vitaminer-och-antioxidanter/d-vitamin.

66.Mohty M, Kuentz M, Michallet M, Bourhis JH, Milpied N, Sutton L, et al. Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: long-term results of a randomized study. Blood. 2002;100(9):3128-34.